[CAR-T immunotherapy in pediatric hemato-oncology… present and future]

An Pediatr (Engl Ed). 2020 Jul;93(1):1-3. doi: 10.1016/j.anpedi.2020.04.023. Epub 2020 Jun 8.

[Article in Spanish]

Authors

Manel Juan¹, Susana Rives²

Affiliations

¹ Hospital Sant Joan de Déu, Plataforma de Inmunoterapia Celular SJD-Clínic, Barcelona, España; Hospital Clínic de Barcelona, Barcelona, España; Universitat de Barcelona, IDIBAPS, Plataforma BST-Clínic, Barcelona, España. Electronic address: mjuan@clinic.cat.
² Hospital Sant Joan de Déu, Plataforma de Inmunoterapia Celular SJD-Clínic, Barcelona, España; Institut de Recerca Hospital Sant Joan de Déu de Barcelona (IRP-HSJD), Barcelona, España.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Child
Humans
Immunologic Factors
Immunotherapy
Medical Oncology
Receptors, Chimeric Antigen*

Substances

Immunologic Factors
Receptors, Chimeric Antigen